These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20107484)

  • 21. CD4 T cell activation by B cells in human Leishmania (Viannia) infection.
    Rodriguez-Pinto D; Saravia NG; McMahon-Pratt D
    BMC Infect Dis; 2014 Feb; 14():108. PubMed ID: 24568275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic responsiveness in American cutaneous leishmaniasis lesions.
    Pirmez C; Cooper C; Paes-Oliveira M; Schubach A; Torigian VK; Modlin RL
    J Immunol; 1990 Nov; 145(9):3100-4. PubMed ID: 1976709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased production of interferon-gamma by Leishmania homologue of the mammalian receptor for activated C kinase-reactive CD4+ T cells among human blood mononuclear cells: an early marker of exposure to Leishmania?
    Bourreau E; Pascalis H; Prévot G; Kariminia A; Jolly N; Milon G; Buffet P; Michel R; Meynard JB; Boutin JP; Aschimoff D; Launois P
    Scand J Immunol; 2003 Aug; 58(2):201-10. PubMed ID: 12869142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma gondii-specific CD4+ T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion.
    Prigione I; Facchetti P; Ghiotto F; Tasso P; Pistoia V
    Eur J Immunol; 1995 May; 25(5):1298-305. PubMed ID: 7774633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.
    Costa DL; Guimarães LH; Cardoso TM; Queiroz A; Lago E; Roselino AM; Bacellar O; Carvalho EM; Silva JS
    Hum Immunol; 2013 Dec; 74(12):1491-500. PubMed ID: 23993989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.
    Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H
    Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
    Ferraz R; Cunha CF; Gomes-Silva A; Schubach AO; Pimentel MI; Lyra MR; Mendonça SC; Valete-Rosalino CM; Da-Cruz AM; Bertho ÁL
    BMC Infect Dis; 2015 Feb; 15():74. PubMed ID: 25870976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis.
    Dórea RC; Coutinho SG; Sabroza PC; Hendriks J; Cysne L; Conceição-Silva F
    Clin Exp Immunol; 1988 Jan; 71(1):26-31. PubMed ID: 3258203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.
    Nateghi Rostami M; Keshavarz H; Edalat R; Sarrafnejad A; Shahrestani T; Mahboudi F; Khamesipour A
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e845. PubMed ID: 20967288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
    Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
    Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.
    Mendonca SC; De Luca PM; Mayrink W; Restom TG; Conceicao-Silva F; Da-Cruz AM; Bertho AL; Da Costa CA; Genaro O; Toledo VP
    Am J Trop Med Hyg; 1995 Aug; 53(2):195-201. PubMed ID: 7677224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Profile Involving CD23/IgE-mediated NO Release is a Hallmark of Cutaneous Leishmaniasis Patients from the Xakriabá Indigenous Community in Minas Gerais, Brazil.
    Carvalho-Gontijo R; Peruhype-Magalhães V; Costa-Silva MF; Martins-Filho OA; Quaresma PF; Freire Jde M; Moreno Ede C; Teixeira-Carvalho A; Gontijo CM
    Scand J Immunol; 2015 Jun; 81(6):515-24. PubMed ID: 25802003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells.
    Campanelli AP; Roselino AM; Cavassani KA; Pereira MS; Mortara RA; Brodskyn CI; Goncalves HS; Belkaid Y; Barral-Netto M; Barral A; Silva JS
    J Infect Dis; 2006 May; 193(9):1313-22. PubMed ID: 16586370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Th2-Type Response Is Associated With Exuberant Lesions in Pregnant Women Infected With Leishmania braziliensis.
    Dutra WO; Barbosa DF; de Souza PEA; Morgan D; Poetker S; Guimarães LH; Bacelar O; Gollob KJ; Carvalho EM
    J Infect Dis; 2019 Jan; 219(3):480-488. PubMed ID: 30165577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.
    Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.
    de Oliveira Mendes-Aguiar C; Vieira-Gonçalves R; Guimarães LH; de Oliveira-Neto MP; Carvalho EM; Da-Cruz AM
    Clin Exp Immunol; 2016 Aug; 185(2):202-9. PubMed ID: 27059407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
    de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
    Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
    Furco A; Carmagnat M; Chevret S; Garin YJ; Pavie J; De Castro N; Charron D; Derouin F; Rabian C; Molina JM
    AIDS; 2008 Oct; 22(16):2087-96. PubMed ID: 18832872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell mediated immune responses to Toxoplasma gondii in pregnant women with primary toxoplasmosis.
    Prigione I; Chiesa S; Taverna P; Ceccarelli R; Frulio R; Morandi F; Bocca P; Cesbron-Delauw MF; Pistoia V
    Microbes Infect; 2006 Feb; 8(2):552-60. PubMed ID: 16324868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.